List of Sodium Nitrite drug patents

Sodium Nitrite is owned by Hope Pharms.

Sodium Nitrite contains Sodium Nitrite.

Sodium Nitrite has a total of 2 drug patents out of which 0 drug patents have expired.

Sodium Nitrite was authorised for market use on 14 February, 2012.

Sodium Nitrite is available in solution;intravenous dosage forms.

Sodium Nitrite can be used as sodium nitrite injection is administered by intravenous injection; sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning.

The generics of Sodium Nitrite are possible to be released after 24 December, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Feb, 2030

(7 years from now)

Drugs and Companies using SODIUM NITRITE ingredient

Market Authorisation Date: 14 February, 2012

Treatment: Sodium nitrite injection is administered by intravenous injection; Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic